ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 85 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,035 | -28.8% | 659,750 | 0.0% | 0.11% | -26.4% |
| Q2 2023 | $4,262 | -14.3% | 659,750 | 0.0% | 0.15% | -31.5% |
| Q1 2023 | $4,975 | -99.9% | 659,750 | 0.0% | 0.22% | -34.7% |
| Q4 2022 | $6,683,268 | +2.4% | 659,750 | 0.0% | 0.33% | -10.5% |
| Q3 2022 | $6,525,000 | -7.1% | 659,750 | 0.0% | 0.37% | -27.2% |
| Q2 2022 | $7,026,000 | +9.2% | 659,750 | 0.0% | 0.51% | +82.1% |
| Q1 2022 | $6,433,000 | -31.8% | 659,750 | 0.0% | 0.28% | -18.4% |
| Q4 2021 | $9,434,000 | -28.6% | 659,750 | 0.0% | 0.34% | -20.3% |
| Q3 2021 | $13,221,000 | -41.0% | 659,750 | 0.0% | 0.43% | -13.3% |
| Q1 2021 | $22,405,000 | -15.6% | 659,750 | 0.0% | 0.50% | -30.8% |
| Q4 2020 | $26,548,000 | – | 659,750 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |